Top

Reactions Weekly

Published in:

01-01-2022 | NSCLC | Case report

Alectinib

Hepatotoxicity: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Urbanska EM, et al. Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery. Clinical Lung Cancer 22: e528-e532, No. 4, Jul 2021. Available from: URL: http://www.journals.elsevier.com/clinical-lung-cancer/

Title: Alectinib
Hepatotoxicity: case report
Publication date: 01-01-2022
Publisher: Springer International Publishing
Keywords: NSCLC
NSCLC
Radiotherapy
Alectinib
Brigatinib
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-08364-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Alectinib

Hepatotoxicity: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Nifurtimox

Atezolizumab

Heparin

Multiple drugs

Carfilzomib

Carboplatin/paclitaxel